2 results match your criteria: "Academy of Clinical Medicine Sciences of Jiangxi Province[Affiliation]"
[Research Progress of Transmembrane Protein Abnormality in Non-Hodgkin's Lymphoma --Review].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
October 2022
Hematology Medical Center of The First Affiliated Hospital of Nanchang University, Institute of Hematology, Academy of Clinical Medicine Sciences of Jiangxi Province, Institute of Lymphatic Tumor Diseases of Nanchang University, Nanchang 330006, Jiangxi Province, China,E-mail:
Transmembrane protein, also known as integral membrane protein, can be distributed in the lipid bilayer or across the entire membrane, and it plays an important role in cell signal transduction. It has been discovered that multiple transmembrane proteins are involved in the regulation of tumor signals. Recent studies have revealed that the abnormal expression of some transmembrane protein is closely related to the occurrence, development and prognosis of non-Hodgkin's lymphoma (NHL), including programmed cell death protein 1 (PD-1), TMEM30A, NOTCH1, TOLL-like receptor (TLR), sphingosine-1-phosphate receptor, TRAIL, etc.
View Article and Find Full Text PDF[Current Advances in the Fecal Microbiota Transplantation and Its Application in the Hematologic Diseases--Review].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
February 2019
Department of Hematology, The First Affiliated Hospital of Nanchang University.Nanchang 330006, Jiangxi Province, China.Institute of Hematology, Academy of Clinical Medicine Sciences of Jiangxi Province, Nanchang 330006, Jiangxi Province, China.E-mail:
Article Synopsis
- The intestinal microbiome is crucial for human health, impacting immune response, metabolism, and disease processes.
- Fecal microbiota transplantation (FMT) is effectively used to treat recurrent Clostridium difficile infections and shows promise for disorders linked to microbial imbalances.
- Current research on FMT for hematologic conditions is scarce, but there are reported improvements in immune thrombocytopenic purpura, CDI, and aGVHD after hematopoietic stem cell transplantation.